3D Bioprinted Tissue Model with Parallel Vessel Walls

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprinting methods fail to create tissue models with channels that match the cross-section of native vessels in living organisms, and the printing of vessel walls according to a pattern parallel to the channel axis is not effectively addressed, leading to risks of coagulation inside bionic organs.

Innovation Solution

A method for manufacturing a perfusable three-dimensional tissue model using 3D bioprinting, where the vascular system is bioprinted using extrusive methods with bioink, and the walls of the channel are printed parallel to the channel axis, using bioinks with specific compositions and properties to ensure structural integrity and cell viability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If the vascular system is bioprinted with walls opening and closing the channel printed perpendicular to the channel axis, then the manufacturing process is simpler, but the risk of coagulation inside the bionic organ increases

Engineering Contradiction:
Improvesimplicity of vascular system printingVSAvoidrisk of coagulation inside bionic organ
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies different printing orientations to different regions of the vascular system. The channel walls are printed parallel to the channel axis in critical regions where coagulation risk is highest, while other regions may use different orientations. This localized optimization resolves the contradiction by applying the most reliable printing method where needed without compromising overall manufacturing simplicity.

Inventive Principle:
Principle #3Local quality

2Ease of manufacture

If the channel cross-section does not match the cross-section of native vessels, then the manufacturing process is easier, but the perfusion function and safety of bionic organs are compromised

Engineering Contradiction:
Improveease of channel formationVSAvoidperfusional function and safety
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent employs parameter changes in the bioink formulation and printing process to achieve precise control over channel cross-sectional geometry. By adjusting bioink viscosity, printing pressure, nozzle diameter, and layer thickness parameters, the channel cross-section is optimized to match native vessel geometry, thereby ensuring proper perfusion function while maintaining manufacturability through controlled parameter adjustment.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the walls closing the channel are printed parallel to the channel axis, then the risk of coagulation is reduced, but the manufacturing complexity increases

Engineering Contradiction:
Improvereduction of coagulation riskVSAvoidcomplexity of printing pattern
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the vascular system printing into distinct functional components: channel formation, wall construction, and lumen definition. By dividing the complex task of printing parallel walls into separate printing steps and using multi-nozzle systems, the manufacturing complexity is managed through systematic segmentation rather than monolithic processing.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses supporting bioink materials and temporary structures as intermediaries during the printing process. These intermediaries enable the formation of parallel walls and proper channel geometry during printing, then are removed or integrated afterward. This intermediary approach simplifies the actual wall printing process while achieving the desired parallel orientation to prevent coagulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables the creation of tissue models with channels that mimic the cross-section of native vessels, reducing the risk of coagulation and ensuring the perfusion of fluids, thereby enhancing the functionality and safety of bionic organs.

Implementation Method 1

placing the resulting system in an incubator, in a temperature in which bioink for printing the vascular system undergoes melt

Methodology Applied
Scientific EffectPhase change: Phase Change

Data Source

PatentUS20250197813A1A method for manufacturing a perfusable three-dimensional tissue model with 3D bioprinting technology, and a tissue model produced with this method
Publication Date: 2025.06.19 POLBIONICA SP Z O O
  • US20250197813A1 patent drawing
  • US20250197813A1 patent drawing
  • US20250197813A1 patent drawing

AI summary

A method For manuFacturing a perFusable three-dimensional tissue model, containing therein a channel distributed across its entire structure, enabling the Flow oF Fluids, wherein bioprinting a vascular system with the extrusive method using bioink, the walls opening and closing the channel in its upper part being printed parallel to the channel axis, and bioprinting oF the model body with the extrusive method using bioink, the bioink For printing the body being diFFerent From the bioink used For bioprinting the vessels, placing the resulting system in an incubator, in a temperature in which bioink For printing the vascular system undergoes melt, removing the bioink, optionally, causing growth in the channel by means oF cells in a medium, wherein, the cross-section oF the channel being the same as the cross-section oF native vessels present in a living organism. The inventions relates to a bionic model with a perFusable system.